Understanding the engagement of key decision support persons in patient decision making around breast cancer treatment by Veenstra, Christine M. et al.
This is the author manuscript accepted for publication and has undergone full peer review 
but has not been through the copyediting, typesetting, pagination and proofreading process, 
which may lead to differences between this version and the Version of Record. Please cite 
this article as doi: 10.1002/cncr.31956 
This article is protected by copyright. All rights reserved 
 
DR. CHRISTINE M VEENSTRA (Orcid ID : 0000-0001-9947-7156) 
DR. LAUREN P WALLNER (Orcid ID : 0000-0002-1279-8617) 
 
 
Article type      : Original Article 
 
 
Understanding the Engagement of Key Decision Support Persons in Patient 
Decision Making Around Breast Cancer Treatment 
 
Running Title: Decision Supporters in Breast Cancer 
 
Christine M. Veenstra, MD, MSHP1,2; Lauren P. Wallner, PhD2,3,4; Paul Abrahamse, 
MA5; Nancy K. Janz, PhD2,6; Steven J. Katz, MD2,3,7; Sarah T. Hawley, PhD
 
2,3,6,7,8
 
1. Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, 
Ann Arbor, MI 
2. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan 
3. Department of Internal Medicine, University of Michigan, Ann Arbor, MI 
4. Department of Epidemiology, University of Michigan, Ann Arbor, MI 
5. Department of Biostatistics, University of Michigan, Ann Arbor, MI 
6. Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, MI 
7. Department of Health Management and Policy, University of Michigan, Ann Arbor, MI 
8. Ann Arbor Veterans Affairs Center for Clinical Management Research, Ann Arbor, Michigan 
 
 
Corresponding Author: 
Christine M. Veenstra, MD, MSHP 
300 North Ingalls, NIB A
ut
ho
r M
an
us
cr
ip
t
This article is protected by copyright. All rights reserved 
Room 3A22 
Ann Arbor, MI 48109 
(734) 615-4762 - phone 
(734) 936-4940 - fax 
cveenstr@med.umich.edu  
 
Text pages: 19 
Number of Tables: 4 
Number of Figures: 1 
 
Funding Sources: This work was funded by grants P01CA163233 to the University of 
Michigan from the National Cancer Institute and RSG-14-035-01 from the American 
Cancer Society. 
Cancer incidence data collection was supported by the California Department of Public 
Health pursuant to California Health and Safety Code Section 103885; Centers for 
Disease Control and Prevention’s (CDC) National Program of Cancer Registries, under 
cooperative agreement 5NU58DP003862-04/DP003862; the NCI’s Surveillance, 
Epidemiology and End Results Program under contract HHSN261201000140C awarded 
to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded 
to the University of Southern California, and contract HHSN261201000034C awarded to 
the Public Health Institute. Cancer incidence data collection in Georgia was supported by 
contract HHSN261201300015I, Task Order HHSN26100006 from the NCI and 
cooperative agreement 5NU58DP003875-04-00 from the CDC. The ideas and opinions 
expressed herein are those of the authors. The State of California, Department of Public 
Health, the NCI, and the CDC and their Contractors and Subcontractors had no role in 
design and conduct of the study; collection, management, analysis, and interpretation of 
the data; and preparation, review, or approval of the manuscript. 
Dr. Veenstra was supported by grant K07 CA196752-01 from the NCI and a Cancer 
Control and Population Sciences Career Development Award from the University of 
Michigan Comprehensive Cancer Center.   
 
Au
th
or
 M
an
us
cr
ip
t
This article is protected by copyright. All rights reserved 
Conflicts of Interest: None 
 
Author Contributions: 
Christine Veenstra: conceptualization, methodology, investigation, writing original 
draft, writing review and editing, visualization 
Paul Abrahamse: methodology, software, formal analysis, investigation, writing original 
draft, writing review and editing, visualization 
Lauren Wallner: writing original draft, writing review and editing, and visualization 
Nancy Janz: conceptualization, methodology, investigation, writing review and editing 
Steven Katz: conceptualization, methodology, investigation, writing review and editing 
Sarah Hawley: conceptualization, methodology, investigation, writing original draft, 
writing review and editing, visualization 
 
Precis: In this population-based study using innovative methodology, informal decision 
support persons were engaged with and positively contributed to patients’ treatment 
decision making. To improve decision quality, future interventions should incorporate 
decision support persons. 
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ABSTRACT 
 
Background: Breast cancer patients involve multiple decision support persons (DSPs) in 
treatment decision making, yet little is known about DSP engagement in decision making 
and association with patient appraisal of the decision process.  
 
Methods: Newly diagnosed breast cancer patients reported to Georgia and LA SEER 
registries in 2014-15 were surveyed 7 months after diagnosis. The individual most 
involved in the respondent’s decision making (key DSP) was surveyed. DSP engagement 
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was measured across 3 domains: 1) Informed about decisions; 2) Involved in decisions; 3) 
Aware of patients’ preferences. Patient decision appraisal included subjective decision 
quality and deliberation. We evaluated bivariate associations using chi-square tests 
between domains of DSP engagement and DSP independent variables. We used Anova 
and multivariable logistic regression to compare domains of DSP engagement with 
patient decision appraisal. 
 
Results: 2502 patients (68% RR) and 1203 eligible DSPs (70% RR) responded. Most 
DSPs were husbands/partners or daughters, white, and college graduates. 
Husbands/partners were more likely to be more informed, involved, and aware (all 
p<0.001). English- and Spanish-speaking Latinos had higher extent of (p 0.017), but 
lower satisfaction with involvement (p<0.001). A highly informed DSP was associated 
with higher odds of patient-reported subjective decision quality (OR 1.46; 95% CI 1.03-
2.08, p=0.03). A highly aware DSP was associated with higher odds of patient-reported 
deliberation (OR 1.83; 95% CI 1.36-2.47, p<.001). 
 
Conclusions: In this population-based study, informal DSPs were engaged with and 
positively contributed to patients’ treatment decision making. To improve decision 
quality, future interventions should incorporate DSPs. 
 
Key Words: breast cancer, social support, significant others, decision making, treatment 
 
 
 
 
 
 
 
 
 
 
Au
th
or
 M
an
us
cr
ip
t
This article is protected by copyright. All rights reserved 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
Patients with cancer face complex decisions spanning the cancer care continuum. 
Ensuring that decisions are high quality, defined as being both informed (based on 
accurate understanding of the options) and values-concordant (consistent with the 
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patients’ underlying values) is a key element of patient-centered care.1,2 The importance 
of others, including family and friends, to achieving patient-centered care has been 
highlighted.3 However, relatively little is known about how informal decision support 
persons (DSPs)—unpaid family or friends distinct from paid caregivers and the health 
care team4
Patients with breast cancer report substantial informal care support even at the 
time of initial doctors visits. We previously found that 77% of patients had someone with 
them at their surgical appointment.
—engage with patients in the treatment decision making process.  
5
 We further found that while 90% reported at least 
one key DSP was involved in their treatment decisions, there was wide variation in the 
size and influence of this network.6 This raises the possibility that some DSPs are less 
engaged in decision making than others. However, little research has been done on DSP 
engagement in the medical decision-making process and even less is known about how 
such engagement influences the quality of patient decision making and patient outcomes. 
To date, most research regarding the role of others in breast cancer treatment decision 
making is limited by patient reports using small samples that lack racial and ethnic 
diversity. Furthermore, this research focuses on spouses, when nearly 40% of newly 
diagnosed breast cancer patients are unpartnered.7
To fill these gaps we undertook a study using a unique dataset consisting of paired 
data from patients with early stage breast cancer and their key DSPs. Our aims were to 
better understand DSP-reported engagement in patients’ treatment decision making 
process and to investigate associations between DSP engagement and patients’ appraisal 
of their treatment decisions.   
 
 
METHODS 
 
Study population 
As described previously,8 the Individualized Cancer Care (iCanCare) Study is a 
large, population-based survey study of women with breast cancer. We accrued 3930 
women, ages 20-79, with newly diagnosed, stage 0-II breast cancer as reported to the 
SEER registries of Georgia and Los Angeles County in 2014-2015. Exclusion criteria 
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included Stage III or IV disease, tumors > 5cm, and inability to complete a questionnaire 
in English or Spanish (N= 258).  
Patients were identified via rapid case ascertainment from surgical pathology 
reports and were mailed surveys approximately 2 months after surgery (median time from 
diagnosis to survey completion: 7 months). We provided a $20 cash incentive and used a 
modified Dillman approach, including post-card reminders and phone reminders with the 
option to complete the survey during a phone interview in Spanish or English.9-11 All 
materials were sent in Spanish and English to those with Spanish surnames.5,9
Patients were asked to complete a table describing individuals who played a key 
role in decisions about locoregional and systemic treatment.
 Survey 
responses were merged with SEER clinical data.  
8
The study was approved by the University of Michigan Institutional Review 
Board and the state and institutional (Emory University and University of Southern 
California) IRBs of the SEER registries.  
 They were then instructed 
to think about the person who was “most helpful” in these decisions (key DSP) and asked 
to either: 1) provide the name and mailing address of this individual directly to our 
research team, or 2) receive a survey packet to deliver to this individual (including 
mailing if needed; postage included). Eligible DSPs were 21 years of age or older, able to 
read English or Spanish, and resided in the United States. Study enrollment is diagramed 
in Figure 1. Of 1713 eligible key DSPs surveyed, 783 surveys were sent directly to the 
DSP and 930 were given to DSP via patients.  
 
Measures 
Questionnaire content was developed based on a conceptual framework derived from 
research on couples dealing with cancer developed by Northouse,12 and informed by 
research on the role of others in decision making.7,13-15
 
 We utilized standard techniques to 
assess content validity, including expert reviews and cognitive pretesting and pilot testing 
of measures in selected patient and DSP populations. 
DSP Engagement: Guided by our conceptual framework, we asked DSPs about 3 
domains of engagement in decision making developed from the concept of patient-
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centered care: 1) feeling informed about decisions; 2) feeling involved in decisions 
(extent of and satisfaction with involvement); 3) feeling aware of patients’ underlying 
values and treatment preferences. The items that comprise each domain are based on 
existing measures or prior studies of breast cancer patients,7,15-19 our work surveying 
significant others,15
Table 1 shows the specific items that comprise each domain of engagement. The 
domain of feeling informed was measured by asking DSPs whether they had received 
enough information about various aspects of therapy (y/n). Responses were tabulated as a 
count of the number of items for which DSPs responded that they received enough 
information and scored from 0-5 (Cronbach alpha=0.82), with higher scores indicating a 
higher degree of being informed. 
 and our cognitive pretesting and piloting in preparation for this study. 
We used factor analysis, Cronbach’s alphas, and Item Response Theory to assess each 
domain of DSP engagement and re-scaled each domain to a 5-point scale for ease of use.  
The domain of feeling involved was measured by asking DSPs to report on the 
extent of and satisfaction with their involvement in the decision making process. Extent 
of involvement was measured by 6 items asking DSPs how often they attended 
appointments, took notes, talked or shared information about treatment options, helped 
manage side effects, and took the patient to appointments (5-pt Likert scale, Not at All to 
Almost Always). Responses to these items were averaged to create a composite scale 
(Cronbach alpha=0.80), with higher scores indicating greater involvement. Satisfaction 
with involvement was measured by 4 items asking DSPs’ level of satisfaction with their 
involvement in patients’ decisions (5-pt Likert scale, Not at All to Very Much). 
Responses to these items were averaged to create a composite scale (Cronbach 
alpha=0.83), with higher scores indicating higher levels of satisfaction. 
The domain of feeling aware was measured by 4 items asking DSPs how much 
the patient discussed treatment preferences with them (4-pt Likert scale, Not at all to A 
Lot). Responses to these items were averaged to create a composite scale (Cronbach 
alpha=0.76), with higher scores indicating higher levels of awareness. All four scales 
were rescaled to range from 0 to 5, for ease of comparison. 
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Other DSP Variables: DSPs were asked to specify their relationship to the patient and 
were then categorized into DSP types: husband/partner, daughter, other family member, 
or friend/other non-family member. DSPs also reported their age, race and ethnicity 
(including primary language spoken among Latino DSPs), and educational attainment 
(high school graduate or less, some college, college degree or more). We also assessed 
DSPs’ objective knowledge about different treatment options using a validated 5-item 
knowledge scale for locoregional treatment20 adapted from a prior 12-item knowledge 
scale.21
 
  
Patient Independent Variables: Because of expected co-linearity between DSP and 
patient sociodemographic factors, only relevant patient clinical factors were included in 
these analyses.  Patients reported their comorbid health conditions (0, 1+) and their 
cancer treatment, consistent with prior work,22
 
 including receipt of chemotherapy (y/n), 
radiation therapy (y/n), and primary surgical treatment (lumpectomy, mastectomy). 
Breast cancer stage (0, I, II) was obtained from SEER. 
Measures of Patient Appraisal of Decision Making: We assessed two related but 
distinct domains of patients’ appraisal of their own decision making: 1) subjective 
decision quality (SDQ), and 2) deliberation, or extent of “thinking through” the treatment 
options. As previously reported,23,24 SDQ was measured using a 5-item scale assessing 
the degree to which patients felt informed, involved, satisfied and not regretful with the 
locoregional treatment decision making process. Deliberation was measured using a 4-
item scale developed from a public deliberation scale6 assessing the degree to which 
patients thought through their treatment-related decisions. Consistent with prior studies, 
both measures were dichotomized with high and low cut points; an overall SDQ score > 4 
indicated greater SDQ9,25 and an overall deliberation score > 4 a more deliberative 
decision.26
 
  
Statistical Analyses 
Analyses were performed in two steps. First, we investigated decision outcomes 
among all patients for associations between whether or not a patient had a DSP and her 
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SDQ and deliberation. Then, among those patients with paired data from a key DSP, we 
investigated the components of DSP engagement and associations between DSP 
engagement and patient decision outcomes. We evaluated bivariate associations using 
chi-square tests between each domain of DSP engagement (Informed, Involved, Aware) 
and DSP independent variables. We used Anova and multivariable logistic regression to 
compare the domains of DSP engagement with the patient-reported decision outcomes of 
SDQ and deliberation. 
To reduce potential bias due to non-response, weights were created using a 
logistic regression of DSP non-response on demographic characteristics of the patients, 
and used in multivariable analysis.27
 
 All statistical tests were 2-sided; p-values<0.05 were 
considered significant. Analyses were conducted with SAS 9.4 (Cary, NC). 
RESULTS 
Study Cohort 
Of 3,672 eligible patients surveyed, 2,502 completed the survey (68% response 
rate). 1203 DSPs returned surveys (70% response rate), for a final analytic cohort for this 
paper of 1203 patients and their corresponding key DSP. Response rates were 
significantly lower for DSPs of patients who were non-white, lower income, unpartnered, 
and in Georgia.  
Decision Outcomes in Patients With and Without DSPs 
 Of 2502 patients who responded to the survey, 81 (3%) said they had no DSP. 
Compared with patients who had at least 1 DSP (whether or not they provided their 
contact information), patients with no DSPs had lower mean deliberation scores (mean 
difference 0.54, 95% CI 0.29-0.79; p<0.01). There was no significant association 
between whether or not patients had a DSP and SDQ (data not shown).  
DSP Characteristics 
Just under half (43%) of DSPs were husbands/partners; 23% were daughters, 23% 
were other family members, and 10% were friends or other non-family members. Most 
DSPs were age 65 or under, white, and college graduates, and 21% were Latino, 17% 
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were black, and 20% had a high school education or less. Among patients, 56% had Stage 
I disease. Just over 30% received chemotherapy, 50% received radiation, 62% underwent 
lumpectomy and 38% underwent mastectomy (including unilateral or bilateral) (Table 2). 
Further details regarding variations in DSP type and characteristics, by patient 
characteristics, have been reported previously.6
Engagement Measures and Engagement by DSP Characteristics 
 
In bivariate analyses husbands/partners were significantly more likely to report 
higher scores on all domains of engagement (informed, involved (extent and satisfaction) 
and aware) than other types of DSPs (all p<0.01). Other findings include a higher mean 
extent of involvement among English- and Spanish-speaking Latinos (p 0.02) compared 
with other racial/ethnic groups, but lower satisfaction with involvement (p<0.01). The 
mean score and interquartile range for each domain, as well as further details of 
variations in DSP engagement by DSP characteristics, are shown in Table 3. 
DSP Engagement and Patient Decision Appraisal 
 
After adjustment for DSP and patient covariates, having a highly informed DSP 
was associated with higher odds of greater patient-reported SDQ (OR 1.46; 95% CI 1.03-
2.08, p=0.03).  Having a highly aware DSP was associated with higher odds of a more 
deliberative decision (OR 1.83; 95% CI 1.36-2.47, p<.01) (Table 4). 
 
DISCUSSION 
In this study we assessed a novel construct—the engagement of key DSPs in the 
decision making process of breast cancer patients—in three domains: informed, involved, 
and aware. We found that DSPs felt highly engaged in the decision-making process and 
that this varied by sociodemographic characteristics of the DSPs.  
Ours is the first study to suggest that among patients with a key DSP, engaging that 
person can have a positive influence on important decision appraisal outcomes, including 
subjective decision quality and deliberation. Our findings suggest that having an 
informed DSP may be one way to achieve better subjective decision quality. This may be 
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because being informed is a key component of subjective decision quality, and the 
informed DSP contributes to that component.23
In prior work we found that women who involved greater numbers of DSPs in their 
treatment decisions reported more deliberative decisions.
 While feeling informed is not the same as 
possessing objective knowledge, our measure of DSPs’ objective knowledge was not 
associated with SDQ.  Importantly, the two measures were not correlated in our data, 
suggesting that it may be that a DSP who feels more informed is better able to provide 
decision support that feels helpful to the patient.  
8
 We believe this analysis 
expands this work by showing that having a more aware key DSP was also associated 
with more deliberation. We acknowledge that a more deliberative decision is not 
necessarily a “good” one; patients and DSPs may spend a lot of time thinking through a 
decision and ultimately choose a treatment against the recommendation of their 
healthcare provider.28 Yet studies suggest the process of decision making is an important 
outcome in itself,29 and that feeling rushed may cause dissatisfaction with this process.23
Our results linking DSP engagement to patient reported decision appraisal have 
important clinical implications. The need for interventions to support patient decision 
making, as a means of improving decision quality and patient-centered care, has been 
identified.
 
Further work to assess the clinical outcomes of these decisions is needed. 
1
Our findings also highlight the potential for interventions aimed at DSPs themselves 
to support engagement with patients in treatment decision making. Such interventions 
could include educational modules to better meet the informational needs of DSPs and 
suggest meaningful ways to become involved in patients’ decision making. Exercises to 
improve DSPs’ awareness of patients’ values and preferences could also be included. Our 
 Our findings and limited other work suggest that in order to have the greatest 
impact, interventions designed to support patient decision making should incorporate 
informal decision supporters. We believe there may be an opportunity for decision aids to 
include modules for patients to view together with their DSPs, and to facilitate interaction 
over geographic distance for DSPs who do not live with or near the patient. Such 
interventions would promote DSP engagement beyond just husbands/partners, potentially 
translating to positive impacts on patients’ decision appraisal. 
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finding that Latino DSPs reported higher extent of, but lower satisfaction with 
involvement is consistent with our prior work identifying a mismatch between actual and 
desired involvement in partners of Latina breast cancer patients.30
Although our study was a large, population-based survey in a diverse sample of 
patients and DSPs with high response rates, and used novel methodology to identify and 
survey DSPs, there are potential limitations. Recall bias is possible; to mitigate this we 
anchored questions around specific memorable activities. It is possible that DSPs who did 
not respond may have had lower engagement. Our innovative measures of DSP 
engagement were based on existing frameworks and subject to extensive pilot testing, but 
we created them de novo and they should be validated in other populations of DSPs and 
cancer patients. The findings for race/ethnicity should be viewed with caution because 
they may reflect cultural differences in how DSPs respond to the questions rather than 
underlying differences in engagement. Finally, our study included only women who 
received breast cancer treatment in Georgia and Los Angeles and their DSPs and 
therefore, may not be geographically generalizable. 
 Together, these results 
suggest a need to help better align patient and DSP expectations and preferences for 
involvement in a potentially vulnerable population where language and health literacy 
may represent barriers to achieving optimal decision processes. Given their high reported 
extent of involvement, Latino DSPs may be an ideal population to include in further 
research as an intervention would not need to “bring them to the table,” but could instead 
focus on maintaining their engagement in a meaningful way. The distinct domains of 
DSP engagement assessed in this study together represent a taxonomy of engagement to 
be further explored in future research.  
 
Conclusions 
Informal decision supporters are engaged in the treatment decision making 
processes of breast cancer patients. Such engagement is associated with positive appraisal 
of this process among patients, yet there are sub-groups of DSPs with low engagement. 
Our work has important clinical implications not just for patients, but for families, who 
are also affected by the cancer and treatment experience. Armed with the knowledge 
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about the key role played by DSPs, clinicians and researchers can develop decision 
support tools to be used by patients along with their DSPs, as well as DSP-facing 
interventions to improve engagement. Ultimately, such tools may improve the quality of 
patients’ decision making, satisfaction with their decisions, and clinical outcomes.     
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Table 1. Domains of DSP-Reported Engagement in Treatment Decisions 
Domain Definition Items 
Informed Knowledge of 
risks & benefits 
of treatment 
options 
When her treatment decisions were being made, did you
• Risks/benefits of surgical treatment options 
 
get enough information about (y/n): 
• Coping with your loved one’s/friend’s cancer & 
treatment • Helping your loved one/friend manage side effects • Long-term effects of treatment • Risk of breast cancer recurrence 
 
Involved Extent of   During the treatment making process how often did you 
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involvement in 
decision making 
 
 
 
 
 
 
 
 
 
Satisfaction with 
involvement in 
decision making 
 
(5-pt scale: Never -Very Often): • Attend doctor appointments where decisions about 
her treatment were discussed  • Take notes for her during a doctor’s appointment • Talk to her about treatment options • Share information with her from other sources
• Help her manage side effects 
 about 
treatment options (e.g., from the internet) 
• Help take her to follow up appointments 
 
Would you say you (5-pt scale: Not at all - Very Much): • Would like to have had more information when 
making treatment decisions • Would like to have participated more in making 
treatment decisions • Are satisfied with the amount of involvement you 
had when your loved one/friend was making 
treatment decisions • Are satisfied that you were adequately informed 
about the issues important to the decision about 
treatment  
 
Aware Of patients’ 
preferences and 
values 
 
 
 
How much did your loved one/friend talk to you about 
how she felt
• Different surgical options 
 about the pros and cons of (4-pt scale: Not 
at All -A Lot): 
• Having radiation • Keeping or losing her breast(s) • Having chemotherapy 
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Table 2: Characteristics of Decision Support Persons (DSPs) and Patients (N=1203 DSPs 
and 1203 patients) 
Characteristic N (%) 
DSP Characteristics 
DSP Type  
  Husband/partner 
  Daughter 
  Other family 
  Friend/Other non-family 
 
512 (43%) 
277 (23%) 
268 (23%) 
122 (10%) 
Age  
  <50 
  51-65 
  >65 
 
469 (40%) 
412 (35%) 
302 (26%) 
Race 
  White 
  Black 
  Asian 
  Latino, English speaking 
  Latino, Spanish speaking 
  Other 
 
629 (53%) 
198 (17%) 
89 (8%) 
160 (13%) 
99 (8%) 
12 (1%) 
Education  
  High school or less 
  Some college 
  College graduate 
 
241 (20%) 
383 (32%) 
563 (47%) 
Patient Characteristics 
Comorbid Conditions 
  0 
  1 or more 
 
800 (67%) 
403 (33%) 
Stage   
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  0 
  I 
  II 
187 (16%) 
653 (56%) 
327 (28%) 
Chemotherapy  
  Yes 
  No 
 
371 (31%) 
811 (69%) 
Radiation  
  Yes 
  No 
 
591 (50%) 
587 (50%) 
Surgery 
  Lumpectomy 
  Mastectomy 
 
747 (62%) 
456 (38%) 
Percents may not add to 100% because of rounding. Ns may not add to 1203 due to 
missing values. 
 
 
 
 
 
 Bivariate Analyses of the Three Domains of DSP Engagement, by DSP Characteristic 
  
(Mean score 
3.75, IQR 3-5) 
d  
(Mean score 
3.82, IQR 2.92-5) 
  
(Mean score 
3.63, IQR 3-4.59) 
  
(Mean score 4.1, 
IQR 3.67-4.83) 
Mean 
Score 
P Mean 
Score 
P Mean 
Score 
P Mean 
Score 
P 
DSP Type 
Husband/partner 
Daughter 
Other family 
 
4.07 
3.55 
3.55 
<0.001  
4.15 
3.95 
3.71 
<0.001  
4.10 
3.81 
3.81 
<0.001  
3.41 
3.18 
3.23 
<0.001 Au
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Friend/Other 
non-family 
3.27 3.18 3.84 3.22 
Age 
<50 
51-65 
>65 
 
3.52 
3.86 
3.98 
0.002  
3.92 
3.91 
3.89 
0.762  
3.84 
3.99 
4.02 
0.074  
3.23 
3.34 
3.32 
0.158 
Race and 
Ethnicity 
White 
Black 
Asian 
Latino, English 
speaking 
Latino, Spanish 
speaking 
 
 
3.82 
3.71 
3.53 
3.55 
 
3.98 
 
0.809  
 
3.91 
3.75 
3.78 
3.97 
 
4.17 
 
0.017  
 
4.19 
3.77 
3.37 
3.82 
 
3.34 
 
<0.001  
 
3.37 
3.10 
3.08 
3.35 
 
3.27 
 
<0.001 
Education 
High school or 
less 
Some college 
College 
graduate 
 
4.10 
 
3.79 
3.63 
0.012  
3.92 
 
3.89 
3.93 
0.610  
3.67 
 
3.96 
4.03 
<0.001  
3.25 
 
3.30 
3.31 
0.647 
IQR: interquartile range 
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 Multivariable Regression Models of Patient Decision Appraisal 
 a b 
 Odds Ratio (95% 
CI) 
P Odd Ratio (95% 
CI) 
P 
Informed 1.46 (1.03 - 2.08) 0.03 0.76 (0.56 - 1.02) 0.06 
Involved 0.89 (0.63 - 1.38) 0.54 0.92 (0.68 – 1.23) 0.57 
Aware 0.86 (0.60 - 1.23) 0.40 1.83 (1.36 – 2.47) <.01 
Objective Knowledge 0.91 (0.66 – 1.27) 0.59 1.25 (0.94 – 1.65) 0.12 
95% CI: 95% Confidence Interval. aDSP race was also significantly associated with 
subjective decision quality. bDSP race and education, as well as patient comorbid 
conditions and surgery type, were also significantly associated with deliberation. 
 
Models 
also adjusted for DSP age, patient stage, receipt of chemotherapy, receipt of radiation, 
and SEER site without significant associations with patient decision appraisal. 
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 Flow of Decision Support Persons (DSPs) into the Study, Starting with the 
Initial Patient Sample.  
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2502 Breast Cancer Patients Surveyed
? 81 patients (3%) have no DSPs
? 365 patients (15%) indicate at least 1 
DSP but do not identify or provide 
contact info for key DSP
? 343 patients (14%) indicate at least 1 
DSP and provide incomplete contact 
info for key DSP or provide info for key 
DSP later determined to be ineligible
1751 Identified Key DSPs
1713 Eligible Key DSPs Surveyed
? 980 sent to patient
? 783 sent to DSP
 
1203 Respondent Key DPSs
(70% Response Rate) 
38 Key DSPs Excluded as Ineligible
? DSP linked to patient who was later 
excluded as ineligible
? Survey respondent said they were not 
DSP (misidentified by patient)
? DSP survey filled out by patient
? DSP deceased or too ill to fill out survey
? DSP does not speak English or Spanish
cncr_31956_f1.eps
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